Clinical Trials in Salt Lake City

Showing 5981-6000 of 16,694 trials

Validation of a Community Pharmacy-Based Prescription Drug Monitoring Program Risk Screening Tool

NCT03936985

The goal of the study is to validate a Prescription Drug Monitoring Program-based opioid risk metric to discriminate between low, moderate, and high-risk opioid use disorder. The World Health Organization Alcohol, Smoking, and Substance Involvement Screening Test (WHO ASSIST) will be used as the gold standard instrument that defines patient risk levels. No intervention or hypothesis will be tested.

Opioid AbusePrescription Drug Abuse (Not Dependent)

University of Utah1,464 participantsStarted Nov 2019

Cincinnati, Ohio, United States • Salt Lake City, Utah, United States

COMPLETEDPhase 3< 1 mile

Study of the Safety of HPN (Hyperion)-100 for the Long-Term Treatment of Urea Cycle Disorders (Treat UCD)

NCT00947297

This was a long-term safety study HPN-100 in urea cycle disorder (UCD) subjects. Subjects were assessed regularly for safety and control of their venous ammonia. Hyperammonemic events were characterized with respect to contributing factors, such as intercurrent illness, diet, and noncompliance with medication.

Urea Cycle Disorders

Amgen60 participantsStarted Nov 2009

Long Beach, California, United States • Los Angeles, California, United States • Stanford, California, United States +19 more locations

Validation of a Community Pharmacy-Based Prescription Drug Monitoring Program Risk Screening Tool

Study of the Safety of HPN (Hyperion)-100 for the Long-Term Treatment of Urea Cycle Disorders (Treat UCD)

Find Trials by Condition in Salt Lake City

Study to Assess the Efficacy and Safety of Nemolizumab (CD14152) in Participants With Prurigo Nodularis (PN)

Effectiveness of a Nutraceutical in Raising Circulating Serum Vitamin, Mineral and Amino Acid Levels in Patients.

Filgotinib in Long-Term Extension Study of Adults With Crohn's Disease

Ibrexafungerp for the Treatment of Complicated Vulvovaginal Candidiasis

Temsirolimus Alone or Paired With Dexamethasone Delivered to the Adventitia to eNhance Clinical Efficacy After Femoropopliteal Revascularization

Pepinemab in Treating Younger Patients With Recurrent, Relapsed, or Refractory Solid Tumors

Phase Ib/2, Multicenter, Dose Escalation Study of DCR-MYC in Patients With Hepatocellular Carcinoma

Feasibility Study on LITT for Medical Refractory Epilepsy

A Study of TL-925 Ophthalmic Emulsion as a Treatment for Dry Eye Disease

Study of GSK3359609 and Pembrolizumab in Programmed Death Receptor 1-ligand 1 (PD-L1) Positive Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Study of the Safety and Tolerability of HPN-100 Compared to Sodium Phenylbutyrate in Children With Urea Cycle Disorders

Impact of Microvascular Inflammation on Kidney Allograft Outcome

A Safety and Effectiveness Study of a New Preservative Free Rewetting Drop

C-myc Biomarker Study for Diabetic Foot Ulcers

Study to Evaluate the Efficacy Safety and Tolerability of Ultevursen in Subjects With RP Due to Mutations in Exon 13 of the USH2A Gene (Sirius)

Safety and Efficacy of ARQ-252 Cream 0.3% in Subjects With Non-Segmental Facial Vitiligo

A Study of the Safety, Efficacy, and Biomarker Response of BMS-986165 in Participants With Moderate to Severe Ulcerative Colitis

Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia